Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christine Decanter"'
Autor:
Manon Mangiardi-Veltin, Clara Sebbag, Christine Rousset-Jablonski, Isabelle Ray-Coquard, Clémentine Berkach, Lucie Laot, Yuting Wang, Inès Abdennebi, Julie Labrosse, Camille Sautter, Aullène Toussaint, Laura Sablone, Enora Laas, Sarah Khallouch, Florence Coussy, Pietro Santulli, Charles Chapron, Angelique Bobrie, William Jacot, Nadir Sella, Elise Dumas, Claire Sénéchal-Davin, Marc Espie, Sylvie Giacchetti, Lorraine Maitrot, Geneviève Plu-Bureau, Charles Coutant, Julien Guerin, Bernard Asselain, Pierre Fumoleau, Manuel Rodrigues, Christine Decanter, Audrey Mailliez, Lidia Delrieu, Amélie Lemoine, Christelle Jouannaud, Doriane Houdre, Fabien Reyal, Anne-Sophie Hamy
Publikováno v:
Reproductive biomedicine online. 44(6)
What are the real-life oncofertility practices in young women diagnosed with breast cancer?The FEERIC (FErtility, prEgnancy, contRaceptIon after breast Cancer in France) study is a web-based cohort study launched with the French collaborative researc
Autor:
Pierre Collinet, Christine Decanter, Anne Laure Barbotin, C. Rubod, Laura M Keller, Charlotte Legrand, Hélène Behal
Publikováno v:
Reproductive biomedicine online. 43(2)
Research question What are ovarian stimulation cycle outcomes and acceptance rates of an oocyte accumulation programme in young women with benign ovarian tumour (BOT)? Design Retrospective cohort study conducted at the Academic Assisted Reproductive
Autor:
Christine Decanter, Audrey Mailliez, Franck Morschhauser, Brigitte Leroy-Martin, Didier Dewailly, Nassima Ramdane, Geoffroy Robin, Laura M Keller, Patrick Devos, Julien Sigalaa
Publikováno v:
Reproductive BioMedicine
Reproductive BioMedicine Online, Elsevier, 2018, 36 (5), pp.543-551. ⟨10.1016/j.rbmo.2018.01.016⟩
2018, 36 (5), pp.543-551. ⟨10.1016/j.rbmo.2018.01.016⟩
Reproductive BioMedicine Online, Elsevier, 2018, 36 (5), pp.543-551. ⟨10.1016/j.rbmo.2018.01.016⟩
2018, 36 (5), pp.543-551. ⟨10.1016/j.rbmo.2018.01.016⟩
International audience; A lower number of metaphase II oocytes eligible for vitrification after controlled stimulation in cancer patients has recently been reported, suggesting that cancer may impair the dynamics and quality of follicular growth. In
Autor:
Christine Decanter, Franck Morschhauser, Catherine Lefebvre, Pascal Pigny, Didier Dewailly, Cécile Gallo
Publikováno v:
Reproductive biomedicine online. 20(2)
Susceptibility of the ovarian reserve to chemotherapy is highly variable from one patient to another and poorly docu- mented. To better characterize the evolution of follicular depletion in patients treated for lymphoma, serum anti-Mullerian hor- mon